Statins benefit over-75s ‘just as much as younger patients’
More data has emerged that lowering LDL cholesterol in old age reduces CV events
Abandoning statins and other lipid-lowering agents in patients over 75 might be misguided with new evidence suggesting good efficacy and safety in reducing cardiovascular risk, researchers say.
Two papers in the Lancet suggest the medication still has a role to reduce a patient’s cumulative lifetime burden of LDL cholesterol, given that CVD risk continues to rise with age.
